Startseite>>Harringtonolide

Harringtonolide (Synonyms: Harringtonolide)

Katalog-Nr.GF11045

Products are for research use only. Not for human use. We do not sell to patients.

Harringtonolide Chemische Struktur

Cas No.: 64761-48-4

Größe Preis Lagerbestand Menge
5mg
876,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products
Harringtonolide is a potent RACK1 inhibitor (IC50=39.66 渭M in A375 cells). Harringtonolide inhibits the epithelial-mesenchymal transition (EMT) process and cell proliferation by affecting the interaction between FAK and RACK1. Harringtonolide has plant growth inhibitory, antiviral, anti-inflammatory, and antiproliferation activities.

Harringtonolide (0-50 渭M; 24 hours) exhibits good antiproliferation activity in A375 cells with IC50 of 39.66 渭M[1].
Harringtonolide (0-20 渭M; 1 hour) restrains the proteolysis of RACK1 by Pronase, and protects temperature-dependent degradation of RACK1[1].
Harringtonolide (0-4 渭M; 24 hours) suppresses the phosphorylation of FAK dose-dependently and inhibits Src and STAT3, the downstream proteins of FAK[1].
Harringtonolide (0-4 渭M; 24 hours) dose-dependently inhibits the RACK1鈥揊AK interaction in A375 cells[1].

[1]. Zhu TY, et al. Photoaffinity Probe Reveals the Potential Target of Harringtonolide for Cancer Cell Migration Inhibition. ACS Med Chem Lett. 2022;13(3):449-456. Published 2022 Feb 2. 

Bewertungen

Review for Harringtonolide

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Harringtonolide

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.